The bill establishes a Cancer Clinical Trial Participation Program in Texas, aimed at increasing participation in cancer clinical trials by providing financial support for ancillary costs incurred by participants. It recognizes that financial barriers, such as transportation and lodging expenses, disproportionately affect individuals from lower-income households, thereby limiting their participation in clinical trials. The program will be developed and implemented by public or private institutions of higher education, independent research organizations, or independent third-party organizations, which will provide reimbursement for costs including travel, lodging, meals, and childcare.

Key provisions of the bill include requirements for collaboration with healthcare providers to inform prospective subjects about the program, a focus on financial need for reimbursement eligibility, and the assurance that reimbursement does not constitute an inducement to participate in trials. The bill clarifies that such reimbursements are intended to eliminate barriers to participation and promote equitable access to clinical trials. Additionally, the program may accept funding from various sources to support its implementation and may collaborate with the Cancer Prevention and Research Institute of Texas.

Statutes affected:
Introduced: ()